Lakefront Biotherapeutics (LKFT) Revenue & Revenue Breakdown
Lakefront Biotherapeutics Revenue Highlights
Latest Revenue (Y)
$1.11B
Latest Revenue (Q)
$6.48M
Lakefront Biotherapeutics Revenue by Period
Lakefront Biotherapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $1.11B | - |
Lakefront Biotherapeutics generated $1.11B in revenue during NA 2025, up 0.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Lakefront Biotherapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | $6.48M | -99.28% |
| 2025-12-31 | $900.82M | 1165.89% |
| 2025-09-30 | $71.16M | 9.00% |
| 2025-06-30 | $65.29M | - |
Lakefront Biotherapeutics generated $6.48M in revenue during Q1 2026, up -99.28% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Lakefront Biotherapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| LKFT | Lakefront Biotherapeutics | $1.11B | $6.48M |
| IOVA | Iovance Biotherapeutics | $263.50M | $121.47M |
| SNDX | Syndax Pharmaceuticals | $172.35M | $83.30M |
| STTK | Shattuck Labs | $1.00M | - |
| GNLX | Genelux | $8.00K | - |
| TRAX | First Tracks Biotherapeutics | - | - |
| NBP | NovaBridge Biosciences | - | - |
| AURA | Aura Biosciences | - | - |
| SLS | SELLAS Life Sciences Group | - | - |
| MLTX | MoonLake Immunotherapeutics | - | - |
| CBIO | Crescent Biopharma | - | - |